Status:
COMPLETED
Electronic Communications and Home Blood Pressure Monitoring
Lead Sponsor:
Kaiser Permanente
Conditions:
Hypertension
Eligibility:
All Genders
25-75 years
Phase:
PHASE3
Brief Summary
The control of blood pressure (BP) for patients with hypertension on medications has been elusive, despite the availability of evidence-based nationally recognized guidelines for treatment and 30 year...
Detailed Description
This is single-blind, randomized, controlled trial, to test the effectiveness of applying the chronic care model to hypertension. There is an emerging consensus that multifaceted, multilevel, interve...
Eligibility Criteria
Inclusion
- Diagnosis of hypertension in the prior two years and on hypertension medications
- Access to the Internet and an e-mail address
- Ability to use a computer using the English language
- Medical care coverage which permits them to refill prescriptions at Group Health Cooperative pharmacies and a willingness to do so.
- Blood pressure on each of two screening visits averaging \> 90 mmHg diastolic or \> 140 mmHg systolic and \< 110 mmHg diastolic or \< 200 mmHg systolic
Exclusion
- Diagnosed or history of diabetes, cardiovascular disease (ischemic heart disease, valvular heart disease, heart failure, arrhythmias, strokes or transient ischemic attacks, and peripheral vascular disease)
- Current treatment for cancer, on immunosuppressant or antiretroviral treatment.
- Surgery or hospitalization in the prior 3 months
- Pregnancy (or plans to become pregnant in the next 12 months)
- Plans to move out of the area or leave the health plan in the next 12 months.
- Upper arm circumference size \> 18 inches.
- Arrhythmia detected at screening visits
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
778 Patients enrolled
Trial Details
Trial ID
NCT00158639
Start Date
June 1 2005
End Date
December 1 2007
Last Update
October 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Group Health Research Institute
Seattle, Washington, United States, 98101